Guillain-Barré Syndrome is a rare neurological disorder in which a person's immune system attacks the peripheral nervous ...

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barré Syndrome (GBS), said <a target=_blank href=http ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its ...

Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...

Valneva (VALN) stock rose after the company posted new Phase 3 trial data for its chikungunya vaccine, Ixchiq, in adolescents aged 12-17. Read more here.

We all know that a healthy, balanced diet dominated by unprocessed foods is a recipe for gut and overall health, but ...

Indian badminton player HS Prannoy is overcoming challenging setbacks, including health issues, to make a comeback.

Samantha Ruth Prabhu has been hitting a slight downward slope lately when it comes to her health. She recently revealed ...